tm
Seeing Is Believing
tm
Seeing Is Believing
Onconova Therapeutics's activity chart (see below) currently has 10 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 80% with an average time for these price targets to be met of 230.2 days.
Most recent stock forecast was given by AHU DEMIR from LADENBURG on 01-Mar-2022. First documented stock forecast 19-Aug-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2022
$7
$-8.95 (-56.11%)
$6.9
4 years 7 months 21 days ago
(01-Mar-2022)
2/2 (100%)
$5.18 (284.62%)
383
Buy Since 13-Nov-2018
$15
6 years 1 months 28 days ago
(24-Aug-2020)
1/1 (100%)
$-47.7 (-76.08%)
318
Buy Since 15-May-2020
$18.75
$10.82 (136.44%)
6 years 5 months 7 days ago
(15-May-2020)
1/1 (100%)
$13.34 (246.58%)
67
Buy Since 19-Aug-2013
$15187485
10 years 10 months 14 days ago
(08-Dec-2015)
0/2 (0%)
$15181635 (259515.12%)
What is ONTX (Onconova Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ONTX (Onconova Therapeutics)?
Which analyst has the current lower performing score on ONTX (Onconova Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONTX (Onconova Therapeutics)?
Which analyst is the currently most bullish on ONTX (Onconova Therapeutics)?
Which analyst is the currently most reserved on ONTX (Onconova Therapeutics)?
